GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hebei Changshan Biochemical Pharmaceutical Co 300255.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

19.58

-0.91%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Hebei Changshan Biochemical Pharmaceutical Co

Its shares trade on Shenzhen under the ticker 300255.SZ. It has been listed since 19 August 2011. In the fiscal year to 31 December 2025, it reported revenue of CN¥875.1m and a net loss of CN¥357.9m. At that date it held total assets of CN¥4.35bn and shareholders' equity of CN¥1.20bn.

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of heparin active pharmaceutical ingredient (API) and heparin preparations. The company is headquartered in Shijiazhuang, Hebei. The company went IPO on 2011-08-19. The firm primarily provides heparin product series. The firm provides sodium heparin active pharmaceutical ingredients (APIs) and hydro-acupuncture preparations. The firm's products are applied primarily in the prevention and treatment of cerebral vascular diseases, hardened arteries, myocardial infarction and phlebitis, among others. The company distributes its products in domestic and overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
19 Aug 2011
Employees
1,306
Website
hbcsbio.com ↗

Leadership

Pay as last reported

  • Mr. Xiaodong GaoChairman of the Board, General Manager, since 2008CN¥1.0m
  • Ms. Jie GaoVice Chairman of the Board, since 2023
  • Ms. Xiaohua YueChief Financial Officer, Deputy General Manager
  • Mr. Zhongying LiuDeputy General Manager, Secretary of the BoardCN¥501,300
  • Mr. Zhenggang QieDeputy General Manager, Director, since 2020CN¥303,800
  • Ms. Yunxia SunDeputy General Manager, Director, since 2021CN¥501,300
  • Ms. Guohong AnDeputy General ManagerCN¥304,900
  • Mr. Yanlu ChangDeputy General Manager
  • Mr. Zhihua LiDeputy General ManagerCN¥500,000
  • Ms. Qing ZhangDeputy General ManagerCN¥935,700
  • Mr. Tao ZhangDeputy General Manager
  • Mr. Xinjun ZhangDeputy General Manager

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.